Benign familial neonatal convulsions (BFNC) is
Introduction
Benign familial neonatal convulsions (BFNC; OMIM 121200) is a rare autosomal inherited epilepsy characterised by unprovoked, generalised or multifocal, tonic-clonic convulsions. Symptoms occur within the first days of life and disappear spontaneously after weeks to months.
Mutations in the genes KCNQ2 and KCNQ3 have recently been shown to cause BFNC. [1] [2] [3] Together with KCNQ1, which is altered in long QT (LQT) syndromes 4, 5 and with KCNQ4, which is mutated in some cases of hereditary hearing impairment, these genes constitute a new sub-family of voltage-gated potassium channel genes. 6 KCNQ2 and KCNQ3 assemble together to build a functional tetrameric channel in the central nervous system. 7, 8 These channels are likely to contribute to the native M-current, a well known slowly activating and deactivating potassium conductance which represents one of the most important regulators of excitability in many neurons. 9 Each channel is made up of six conserved hydrophobic transmembrane spans, including the voltage sensor contained in the S4 helix, an ion channel pore formed partly by the loop between S5 and S6, and a long C-terminal domain. 10 Four BFNC-causing mutations lie in the conserved, carboxyl-terminal portion of the KCNQ2 protein. 11, 12 In the remaining three BFNC cases identified mutations involve the pore region (two cases) or the transmembrane domain S6. 2 The functional expression of some of these mutants in Xenopus oocytes resulted in a 20% drop in repolarising potassium currents compared with the wild type. This reduction impairs repolarisation leading to hyperexcitability of the cell membrane in the regions of the brain where KCNQ2 and KCNQ3 are expressed. 8 Here we describe a large, four-generation Italian family with BFNC harbouring a novel missense mutation in the KCNQ2 S4 helix.
Materials and methods

Subjects
The BFNC kindred had eight affected individuals in four generations ( Figure 1 ). The index patient (IV, 2) aged 12 months, had her first seizure on day 2 after birth, characterised by generalised hypertonia with apnea and cyanosis followed by clonic limb jerks. The seizure lasted about 30 s and recurred on days 4 and 5 with the same semiology; at the age of 3 months a new burst of generalised seizures occurred, but they were successfully controlled by phenobarbital. Her brother (IV, 1) manifested generalised seizures on day 2 and up to day 10; other sporadic seizures appeared at two months of age and no treatment was started. Her mother (III, 4) and the other affected relatives also manifested a few, mild seizures during the first 10 days of life. Collection and analysis of blood samples from all individuals included in this report was performed after appropriate informed consent.
Molecular studies
Segregation of the polymorphic marker D8S558 closely linked to KCNQ3 and of the Thr752Asn polymorphism located on exon 16 of the KCNQ2 gene 9 was studied in the members of the index family (II-4-5, III-3-4-5, IV-1-2). The KCNQ2 coding region including the exon-intron boundaries of patients I-1, II-5-7-9, III-1-4, IV-1-2 and of the unaffected members of the kindred, I-2, II-2-4-6-8, III-2-3-5, were amplified using the primers and the conditions described by Biervert and Steinlein 11 and directly sequenced using an ABI PRISM 310 sequencer and the Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystem, Foster City, CA, USA).
Results
Preliminary study of the index family excluded linkage of BFNC to KCNQ3, whilst linkage to KCNQ2 was not excluded. Therefore, the coding region of KCNQ2 was analysed. A missense mutation in exon 3 C686T predicting the change of arginine of codon 214 to tryptophane (CGG → -TGG) was found in all affected members (Figure 2a) . The same mutation has also been found in the unaffected subject II-2 (the father of patient III-4). He was considered an obligate carrier. The finding is not unexpected because the overall penetrance in BFNC family studies, as determined by the rate of obligate carriers with no clinical manifestations, is 0.8-0.85. 13 The mutation abolishes an AgeI restriction site. None of the 150 Italian independent controls screened showed this mutation. It lies in the highly conserved, key functional S4 domain (Figure 2b ).
Discussion
Voltage-dependent ion channels are regulated by membrane potential. To achieve this regulation, charged voltage sensors in the channel protein respond to changes in the membrane potential and initiate conformational changes that lead to 4 The arginine (R) mutation is shown in bold c Transmembrane structural organization of the K + channel proteins, showing the S1-S6 transmembrane domains and the P pore region. Amino acids substituted in this region and causing BFNC (KCNQ2 or KCNQ3), LQT syndromes (KCNQ1) and DFNA2 (KCNQ4) are distinguished by circles, squares and triangles, respectively. C-terminal mutations are omitted. KCNQ3 mutation causing BFNC is specified. No mutation lies in the S4 domain where the R214W substitution (in bold and underlined) has been found.
KCNQ2 voltage sensor mutation causes epilepsy
channel opening. In voltage gated K + channels, the fourth transmembrane segment (S4) contains conserved, regularly spaced, positively charged residues, making it a strong candidate for the voltage sensor. Analysis of the atomic scale movement of the S4 domain in the Shaker potassium channel measured by spectroscopy has recently clarified the mechanism by which this region functions as a voltage sensor. In the closed state of this model, charged arginines lie within a narrow internal crevice that opens into the intracellular solution. In response to voltage, the S4 undergoes a rotation and tilt, and the charged residues became accessible to the extracellular solution via a narrow external crevice. 14 The R214W mutation neutralises one of the innermost positive charge of the S4 segment. This substitution probably reduces the movement of the voltage sensor that precedes channel opening during voltage-dependent activation. Alternatively, it might have indirect effects on contiguous charged residues, affecting their movement or the electric field that they pass through, or both, in this way altering the voltage sensitivity of channel opening. There are four members belonging to the KQT-like family; two of them (KCNQ2 and KCNQ3) are expressed in the brain and their mutations produce BFNC;
7 KCNQ1 is expressed in heart and the inner ear; mutations affecting this gene cause the Romano-Ward syndrome (the long-QT syndrome linked to chromosome 11) and the Jervell and Lange-Nielsen cardioauditory syndrome. [15] [16] [17] Mutations in KCNQ4, which is expressed in sensory outer hair cells of the cochlea, cause an autosomal dominant non-syndromic deafness (DFNA2). [18] [19] [20] Although several mutations affecting the trans-membrane domains and the pore region have been described in these syndromes none of them involve the S4 domain (Figure 2c ). R214W represents the first description of a mutation involving the K + channel voltage sensor in a human disease associated with altered regulation of cellular excitability. Interestingly, the clinical features of BFNC patients with mutation on the voltage sensor overlap with the phenotypes of BFNC patients with mutations in the pore or in the other transmembrane regions, suggesting a similar effect on current decline.
